Pegus Research, Inc.   Report issue

For profit Phase 3
Founded: Salt Lake City UT United States (1985)
Status: No NME R&D (1985)

Organization Overview

First Clinical Trial
2008
NCT00751400
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Pegus Research, Inc.

Active Ingredients

Drugs in Phase 3 Trials (3)

naproxen (naprosyn) (1 trial)

norgestrel (Ovral) (2 trials)

ulipristal (ella) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Emergencies (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 3